United States - English - NLM (National Library of Medicine)

amneal-agila, llc - nevirapine (unii: 99dk7fvk1h) (nevirapine - unii:99dk7fvk1h) - nevirapine 200 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - lopinavir, quantity: 200 mg; ritonavir, quantity: 50 mg - tablet, film coated - excipient ingredients: sodium stearylfumarate; macrogol 3350; hyprolose; macrogol 400; colloidal anhydrous silica; polysorbate 80; purified talc; copovidone; titanium dioxide; iron oxide yellow; hypromellose; sorbitan monolaurate - kaletra is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older. this indication is based on the analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled clinical studies (see clinical trials).

Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - nevirapine anhydrous - prolonged-release tablet - 400 milligram(s) - non-nucleoside reverse transcriptase inhibitors; nevirapine

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - nevirapine (unii: 99dk7fvk1h) (nevirapine - unii:99dk7fvk1h) - nevirapine is indicated for combination antiretroviral treatment of hiv-1 infection in adults and in pediatrics patients 15 days and older [see clinical studies (14.1) , (14.2) ]. additional important information regarding the use of nevirapine for the treatment of hiv-1 infection: •based on serious and life-threatening hepatotoxicity observed in controlled and uncontrolled trials, nevirapine should not be initiated in adult females with cd4+ cell counts greater than 250 cells/mm3 or in adult males with cd4+ cell counts greater than 400 cells/mm3 unless the benefit outweighs the risk [see boxed warning and warnings and precautions (5.1) ]. •the 14-day lead-in period with nevirapine 200 mg daily dosing must be strictly followed; it has been demonstrated to reduce the frequency of rash [see dosage and administration (2.4) and warnings and precautions (5.2) ]. •if rash persists beyond the 14-day lead-in period, do not dose escalate to 200 mg twice daily. the 200 mg once-daily dosing regimen should not b

United States - English - NLM (National Library of Medicine)

cipla usa inc. - nevirapine hemihydrate (unii: b7xf2td73c) (nevirapine - unii:99dk7fvk1h) - nevirapine is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv-1) infection in adults and pediatric patients 15 days and older [see clinical studies (14.1, 14.2)] . limitations of use: based on serious and life-threatening hepatotoxicity observed in controlled and uncontrolled trials, nevirapine is not recommended to be initiated, unless the benefit outweighs the risk, in: -   adult females with cd4+ cell counts greater than 250 cells/mm3 or -   adult males with cd4+ cell counts greater than 400 cells/mm3 [see warnings and precautions (5.1)] . nevirapine oral suspension is contraindicated: - in patients with moderate or severe (child-pugh class b or c, respectively) hepatic impairment [see warnings and precautions (5.1) and use in specific populations (8.7)] - for use as part of occupational and non-occupational post-exposure prophylaxis (pep) regimens [see warnings and precautions (5.1)] . pregnancy exposure registry t

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - nevirapine anhydrate 400 mg - prolonged-release tablet - 400 mg - nevirapine anhydrate 400 mg - nevirapine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - nevirapine 400 mg - prolonged-release tablet - 400 mg - nevirapine 400 mg - nevirapine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - nevirapine anhydrate - eq. nevirapine 400 mg - prolonged-release tablet - 400 mg - nevirapine anhydrate - nevirapine

Kenya - English - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - nevirapine usp - tablet - nevirapine 200mg - antivirals for systemic use: non-nucleoside

Kenya - English - Pharmacy and Poisons Board

aurobindo pharma limited unit iii plot no. 11 - nevirapine anhydrous - tablet and powder for oral solution - nevirapine anhydrous 50mg - antivirals for systemic use: combinations of